Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. September 2021 14:46 ET | Quelle: iCAD, Inc.

iCAD to Host Educational Roundtable to Help Clinicians and Facilities Recover from COVID-19 Impact

NASHUA, N.H., Sept. 09, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
31. August 2021 08:00 ET | Quelle: iCAD, Inc.

iCAD’s Xoft Brain IORT Demonstrates Significant Improvement in Overall Survival in Recurrent Glioblastoma According to Comparative Study

NASHUA, N.H., Aug. 31, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...
05. August 2021 16:01 ET | Quelle: iCAD, Inc.

iCAD Reports Financial Results for the Quarter Ended June 30, 2021

NASHUA, N.H., Aug. 05, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported its...
02. August 2021 16:05 ET | Quelle: iCAD, Inc.

iCAD to Participate in the Guggenheim MedTech Disruptors Summit

NASHUA, N.H., Aug. 02, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...
22. Juli 2021 16:01 ET | Quelle: iCAD, Inc.

iCAD to Report Second Quarter 2021 Financial Results on Thursday, August 5

NASHUA, N.H., July 22, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
14. Juni 2021 08:00 ET | Quelle: iCAD, Inc.

iCAD’s ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval

NASHUA, N.H., June 14, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...
08. Juni 2021 08:00 ET | Quelle: iCAD, Inc.

iCAD Signs Global Distribution Agreement with Sectra

NASHUA, N.H., June 08, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it has...
17. Mai 2021 16:05 ET | Quelle: iCAD, Inc.

iCAD to Participate in Upcoming Virtual Investor Conferences

NASHUA, N.H., May 17, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael...
17. Mai 2021 08:00 ET | Quelle: iCAD, Inc.

iCAD Announces Educational Webinar Featuring Leading Global Experts Discussing New Multidisciplinary Approach for Treating Brain Tumors, May 25

NASHUA, N.H., May 17, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced a virtual...
28. April 2021 16:01 ET | Quelle: iCAD, Inc.

iCAD Reports Financial Results for First Quarter Ended March 31, 2021

First Quarter Revenues of $8.6 Million Represented 32% Year-Over-Year Growth Driven by 28% Growth in Detection Revenue and 41% Growth in Therapy Revenue ProFound AI® Product Revenue Increased 34%...

Vorherige Seite

Nächste Seite